Inhibition of the main protease of SARS-CoV-2 (M(pro)) by repurposing/designing drug-like substances and utilizing nature’s toolbox of bioactive compounds

The emergence of the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) has resulted in a long pandemic, with numerous cases and victims worldwide and enormous consequences on social and economic life. Although vaccinations have proceeded and provide a valuable shield against the virus, th...

Descripción completa

Detalles Bibliográficos
Autores principales: Antonopoulou, Io, Sapountzaki, Eleftheria, Rova, Ulrika, Christakopoulos, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Research Network of Computational and Structural Biotechnology 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920478/
https://www.ncbi.nlm.nih.gov/pubmed/35308802
http://dx.doi.org/10.1016/j.csbj.2022.03.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920478/
https://www.ncbi.nlm.nih.gov/pubmed/35308802
http://dx.doi.org/10.1016/j.csbj.2022.03.009

Ejemplares similares